Allena Pharmaceuticals Inc (ALNA)

HEALTH CARE: PHARMACEUTICALS
SIC: BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)

ONE NEWTON EXECUTIVE PARK NEWTON, MA 02462

Allena Pharmaceuticals, Inc. operates as a late-stage clinical bio-pharmaceutical company. The Company develops oral enzyme therapeutics to treat patients. Allena Pharmaceuticals also focuses on treating metabolic and orphan diseases such as oxalate and urate. Allena Pharmaceuticals serves patients in the United States.

Data based on most recent fiscal year report
Market Cap60.083 Million Shares Outstanding23.47 Million Avg Volume230.584 Thousand
1-Yr BETA vs S&P TR1.443 Current Ratio11.19 Quick Ratio11.19
View SEC Filings from ALNA instead.

View recent insider trading info

Funds Holding ALNA (via 13F filings)

Refresh Download CSV Download Excel (.xlsx) Download TSV
Filter by:
to
to
to
Refresh
*Shares are split adjusted
*Please note that if a filer hasn't submitted a 13F filing for a quarter then the filer's shares will be listed as "Sold All"

Mutual Funds Holding ALNA BETA

Active Schedule 13D and 13G filings

Please sign in first

Open Market Buys/Sells Last 60 Days

Open Market Buys (P)

none

Open Market Sells (S)

none

Exercise Derivative Conversion (M)

none

Current/Former Insiders

Insider Name Type Last Reported Shares Held Last Reported Date Filings in past year

HADLEY HARBOR MASTER INVESTORS (CAYMAN) L.P.

  • 10% Owner
4,962,678 2020-03-24 0

HACK ANDREW A. F.

  • Director
0 2020-03-11 1

TOPPER JAMES N

  • Director
  • 10% Owner
0 2020-02-12 1

BESSEMER VENTURE PARTNERS VII L.P.

BESSEMER VENTURE PARTNERS VII INSTITUTIONAL L.P.

BVP VII SPECIAL OPPORTUNITY FUND LP

DEER VII & CO. L.P.

DEER VII & CO. LTD.

  • 10% Owner
0 2020-02-10 0

BRENNER LOUIS MD PRESIDENT AND CEO

  • Officer
  • Director
0 2019-12-02 1

WHOLIHAN EDWARD CHIEF FINANCIAL OFFICER

  • Officer
0 2019-12-02 1

ALEXANDER ROBERT CHIEF EXECUTIVE OFFICER

  • Officer
  • Director
477,577 2019-11-29 1

TEPPER ROBERT I

  • Director
  • 10% Owner
0 2019-06-25 1

SANTINI GINO

  • Director
7,284 2019-06-20 1

MARGOLIN ALEXEY L

  • Director
0 2019-06-05 1

BOLTE AXEL

  • Director
0 2019-05-15 0

DIAZ ALLENE M.

  • Director
0 2019-05-06 2

FHM VI, L.L.C.

FHM VI, L.P.

FRAZIER HEALTHCARE VI, L.P.

  • 10% Owner
1,396,615 2018-12-07 0

THIRD ROCK VENTURES II, L.P.

THIRD ROCK VENTURES GP II, L.P.

TRV GP II, LLC

LEVIN MARK J

STARR KEVIN P

  • 10% Owner
2,790,964 2017-11-06 0

HBM BIOCAPITAL II LP

  • 10% Owner
No longer subject to file 2017-11-06 0

KRAUS STEPHEN

  • Director
0 2017-11-06 0

Insider Transactions Last 60 Days

Reporting Owners Transaction Date Transaction Code Shares Share Price Acquired or Disposed Shares Owned Following Transaction Combined shares owned after filing Direct/Indirect Ownership 10b-5
No current insider transactions

Elevate your investments